Data from: Detection of human disease conditions by single-cell morpho-rheological phenotyping of blood

Blood is arguably the most important bodily fluid and its analysis
provides crucial health status information. A first routine measure to
narrow down diagnosis in clinical practice is the differential blood
count, determining the frequency of all major blood cells. What is lacking
to advance initial blood diagnostics is an unbiased and quick functional
assessment of blood that can narrow down the diagnosis and generate
specific hypotheses. To address this need, we introduce the continuous,
cell-by-cell morpho-rheological (MORE) analysis of diluted whole blood,
without labeling, enrichment or separation, at rates of 1,000 cells/sec.
In a drop of blood we can identify all major blood cells and characterize
their pathological changes in several disease conditions in vitro and in
patient samples. This approach takes previous results of mechanical
studies on specifically isolated blood cells to the level of application
directly in blood and adds a functional dimension to conventional blood
analysis.